Published in Lancet on February 01, 1992
Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol (1998) 5.05
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med (2008) 2.74
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol (1995) 1.63
SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma. AIDS Res Hum Retroviruses (2011) 1.13
Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines. J Virol (1999) 1.11
Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut (2002) 1.09
Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc Natl Acad Sci U S A (1992) 1.04
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease. J Virol (2005) 0.90
T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci U S A (1993) 0.89
Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. J Virol (1995) 0.84
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group. Clin Diagn Lab Immunol (1996) 0.78
Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS. PLoS One (2014) 0.75
Where are we now with vaccines against AIDS? BMJ (1993) 0.75
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci U S A (1991) 5.83
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82
Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet (1977) 5.32
Endovascular repair (EVAR) of abdominal aortic aneurysms: the case for. Ann R Coll Surg Engl (2004) 5.11
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98
The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem (2001) 4.74
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A (2000) 4.46
The major medical complications of heroin addiction. Ann Intern Med (1967) 4.16
Avoidable factors contributing to death after head injury. Br Med J (1977) 3.75
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem (1991) 3.51
Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol (2008) 3.41
Generation of human monoclonal antibodies to human immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 3.07
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med (1996) 2.96
Practical considerations in design of internal amplification controls for diagnostic PCR assays. J Clin Microbiol (2004) 2.86
Serological analysis of chicken flocks for antibodies to Salmonella enteritidis. Vet Rec (1990) 2.79
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Salmonella enteritidis phage type 4 from the contents of intact eggs: a study involving naturally infected hens. Epidemiol Infect (1989) 2.52
Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry (1992) 2.44
Transcription of the immediate early genes of human cytomegalovirus strain AD169. Virus Res (1984) 2.38
The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold. Nat Struct Biol (1997) 2.34
Visualization of the bent helix in kinetoplast DNA by electron microscopy. Cell (1986) 2.31
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler (2010) 2.30
Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun (1982) 2.28
Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med (1995) 2.23
Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol (1994) 2.22
Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect Immun (1986) 2.21
Dietary fat and asthma: is there a connection? Eur Respir J (1997) 2.19
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06
Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome. J Gen Virol (1982) 2.05
Estimating the effect of the run-in on the power of the Physicians' Health Study. Stat Med (1991) 2.05
Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology (1997) 2.03
Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis (1985) 2.02
Avoidance of PCR false positives [corrected]. Nature (1990) 2.00
Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke (1994) 2.00
Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke (1997) 1.94
Mood disorders in the year after first stroke. Br J Psychiatry (1991) 1.93
Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89
Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem (1992) 1.88
Plasma membranes: phospholipid and sterol content. Science (1966) 1.87
Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87
Protection against intranasal infection of mice with Bordetella pertussis. Dev Biol Stand (1985) 1.84
Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Diet (2005) 1.81
Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol (1994) 1.77
Emotionalism after stroke. BMJ (1989) 1.76
Sports doctors' resuscitation skills under examination: do they take it seriously? Br J Sports Med (2001) 1.76
Nucleotide sequence of the most abundantly transcribed early gene of human cytomegalovirus strain AD169. Virus Res (1987) 1.73
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry (2004) 1.72
Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer (1997) 1.71
Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. J Clin Endocrinol Metab (1992) 1.66
The pathology of experimental Ebola virus infection in monkeys. J Pathol (1978) 1.66
A highly bent fragment of Crithidia fasciculata kinetoplast DNA. J Biol Chem (1986) 1.66
Pertussis vaccine: present status and future prospects. Vaccine (1985) 1.63
Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J Gen Virol (1997) 1.62
Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62
A comparison of virulence of two strains of Legionella pneumophila based on experimental aerosol infection of guinea-pigs. J Hyg (Lond) (1985) 1.61
Experimental infection of Rhesus monkeys with a human strain of Campylobacter jejuni. J Hyg (Lond) (1981) 1.61
The intelligence of hydrocephalic children. Arch Neurol (1981) 1.60
Hospital services for patients with acute stroke in the United Kingdom: the Stroke Association Survey of consultant opinion. Age Ageing (1995) 1.59
Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. J Infect Dis (1997) 1.57
Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ (1991) 1.57
Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol (1995) 1.56
Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry (2006) 1.54
Poor reading comprehension despite fast word decoding in children with hydrocephalus. Brain Lang (2001) 1.53
Systematic review of prognostic models in patients with acute stroke. Cerebrovasc Dis (2001) 1.52
Strangulation injuries in children. Part 1. Clinical analysis. J Trauma (1996) 1.52
A reproducible animal model of acute bleeding ulcer-the "ulcer maker". Gastroenterology (1976) 1.52
Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol (1985) 1.52
Serological analysis for antibodies to S enteritidis. Vet Rec (1991) 1.52
Social and emotional loneliness: an examination of Weiss's typology of loneliness. J Pers Soc Psychol (1984) 1.52
Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J Hyg (Lond) (1982) 1.51
Alloantigen-stimulated anti-HIV activity. Blood (1998) 1.51
Experimental transmission of legionnaires' disease by exposure to aerosols of Legionella pneumophila. Lancet (1982) 1.50
Isolation and partial characterization of single-stranded adenoviral DNA produced during synthesis of adenovirus type 2 DNA. J Virol (1975) 1.50
Salivary testosterone levels and major depressive illness in men. Br J Psychiatry (1992) 1.49
No confirmation for a causal role of volume-regulated chloride channels in ischemic preconditioning in rabbits. J Mol Cell Cardiol (2000) 1.49
Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies. J Gen Microbiol (1983) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. AIDS Res Hum Retroviruses (1997) 1.48
The structure of glutamine-binding protein complexed with glutamine at 1.94 A resolution: comparisons with other amino acid binding proteins. J Mol Biol (1998) 1.48
Outcome of deliberate self-poisoning. An examination of risk factors for repetition. Br J Psychiatry (1994) 1.45
The war against error: a 15 year experience of completion angioscopy following carotid endarterectomy. Eur J Vasc Endovasc Surg (2011) 1.45
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains. Biochemistry (1987) 1.45
Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res (1987) 1.43
The crystal structure of glutamine-binding protein from Escherichia coli. J Mol Biol (1996) 1.42
Lack of correspondence between the amplitudes of spontaneous potentials and unit potentials evoked by nerve impulses at regenerating neuromuscular junctions. Nat New Biol (1971) 1.41